Wegovy approved in China - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

CBS News on MSN · 1d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

FingerLakes1.com · 5h

Hims stock today tumbles 35% after Novo Nordisk ends Wegovy partnership over legal concerns

Novo Nordisk ends Wegovy deal with Hims over legal issues, sending the stock tumbling. What happens next? Here's a look.

Zacks.com on MSN · 2h

Can Novo Nordisk Regain Ground After Cutting Ties With Hims & Hers?

NVO ends its deal with HIMS over safety concerns tied to compounded Wegovy, hitting patient access and market share plans.

Daily Voice on MSN1d

Plainsboro-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales

Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

Novo Nordisk launches blockbuster weight loss drug Wegovy in India

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

news-expressky.com7h

Rival GLP-1 Weight-Loss Drug Emerges From China

TUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to ...

Hims & Hers stock crashes over 20% on Wegovy shocker

Hims & Hers Health stock plunged after Novo Nordisk (NYSE: NVO) cut ties over concerns about its handling of Wegovy ...

24/7 Wall St.4d

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results